Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium for prevention of paclitaxel-induced neuropathy in breast cancer
2015-004172-30Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Apr 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Lithium carbonate + paclitaxel with Placebo + paclitaxel (2 arms). Started Apr 2021; status: completed.
02
Drugs
lithium carbonate
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on 2015-004172-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004172-30.